t is supplied in 20 mL or 100 mL colourless glass vials with a rubber stopper and aluminium seal. Each pack contains 1 vial.
Ingredients
The active ingredient in ERBITUX 5 mg/mL is cetuximab. Each 20 mL vial contains 100 mg cetuximab and each 100 mL vial contains 500 mg cetuximab.
The solution also contains the following inactive ingredients:
glycine
polysorbate 80
citric acid monohydrate
sodium chloride
water for injections
sodium hydroxide.
ERBITUX solution does not contain any preservative.
Supplier
ERBITUX 5 mg/mL is supplied in Australia by:
Merck Serono Australia Pty Ltd
3-4/25 Frenchs Forest Road East
Frenchs Forest NSW 2086
ERBITUX is supplied in New Zealand by:
Healthcare Logistics
58 Richard Pearse Drive
Airport Oaks
Auckland
For enquiries about ERBITUX please call Merck Serono Australia Medical Information on 1800-MED-INF (1800-633-463) or from New Zealand call +61 2 8977 4100.
Australian registration numbers:
AUST R 132393, 132396
Date of preparation
This leaflet was prepared in
October 2011.
® Registered trademark
A007-1011
|
